<prompt> All the following are indicated in the long-term therapy of children with coronary abnormalities in Kawasaki disease EXCEPT:Intravenous immunoglobulinsAspirinClopidogrelWarfarin  <response>: Treatment of Kawasaki Disease Acute stage Intravenous immunoglobulin 2 gkg over 10-12 hr and Aspirin 80-100 mgkgday divided every 6 hr orally until patient is afebrile for at least 48 hr Convalescent stage Aspirin 3-5 mgkg once daily until 6-8 wk after illness onset if normal coronary findings throughout Long-term therapy for patients with coronary abnormalities Aspirin 3-5 mgkg once daily orally or Clopidogrel 1 mgkgday maximum: 75 mgday Warfarin or low-molecular-weight heparin added for patients at paicularly high risk of thrombosis Acute coronary thrombosis Prompt fibrinolytic therapy with tissue plasminogen activator or other thrombolytic agent 